Evidence map›Paper›PMID 27940183›Full record

Trial reportContemporary clinical trials2017

Randomized controlled dissemination study of community-to-clinic navigation to promote CRC screening: Study design and implications.

Linda Larkey, Laura Szalacha, Patricia Herman, Julie Gonzalez, Usha Menon

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Linda LarkeyArizona State University, College of Nursing and Health Innovation, 550 N 3rd Street, Phoenix, AZ 85004, United States. Electronic address: Linda.Larkey@asu.edu.
Laura SzalachaThe University of Arizona, College of Nursing, 1305 N. Martin, Tucson, AZ 85721, United States.
Patricia HermanRAND Corporation, 1776 Main Street, Santa Monica, CA 90407-2138, United States.
Julie GonzalezArizona State University, College of Nursing and Health Innovation, 550 N 3rd Street, Phoenix, AZ 85004, United States.
Usha MenonThe University of Arizona, College of Nursing, 1305 N. Martin, Tucson, AZ 85721, United States.
Arizona State University · USUniversity of Arizona · USRAND Corporation · US

Funding

Navigation from Community to Clinic to promote CRC Screening in Underserved PopulR01CA162393 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI LARKEY, LINDA K, MENON, USHA · 2012 to 2016
$2.9M
NCI NIH HHS R01 CA162393
6 · The paper itself

Abstract

introductionRegular screening facilitates early diagnosis of colorectal cancer (CRC) and reduction of CRC morbidity and mortality. Screening rates for minorities and low-income populations remain suboptimal. Provider referral for CRC screening is one of the strongest predictors of adherence, but referrals are unlikely among those who have no clinic home (common among poor and minority populations). METHODS/STUDY

designThis group randomized controlled study will test the effectiveness of an evidence based tailored messaging intervention in a community-to-clinic navigation context compared to no navigation. Multicultural, underinsured individuals from community sites will be randomized (by site) to receive CRC screening education only, or education plus navigation. In Phase I, those randomized to education plus navigation will be guided to make a clinic appointment to receive a provider referral for CRC screening. Patients attending clinic appointments will continue to receive navigation until screened (Phase II) regardless of initial arm assignment. We hypothesize that those receiving education plus navigation will be more likely to attend clinic appointments (H1) and show higher rates of screening (H2) compared to those receiving education only. Phase I group assignment will be used as a control variable in analysis of screening follow-through in Phase II. Costs per screening achieved will be evaluated for each condition and the RE-AIM framework will be used to examine dissemination results.

conclusionThe novelty of our study design is the translational dissemination model that will allow us to assess the real-world application of an efficacious intervention previously tested in a randomized controlled trial.

Indexed as

EthnicityMedically UninsuredMinority GroupsPatient CompliancePovertyAgedAsianBlack or African AmericanColorectal NeoplasmsEarly Detection of CancerFemaleHispanic or LatinoHumansIndians, North AmericanMaleMiddle Aged

Identifiers

PMID27940183
PMCPMC6386159
OpenAlexW2560813760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.